European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.61% to 1,444.24 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by Sequans Communications (SQNS) and financial services company ING Groep (ING), which rose 6.8% and 4.2% respectively. They were followed by financial services company Banco Santander (SAN) and biopharmaceutical company Genfit (GNFT), which were up 2.2% each.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and pharmaceutical company Novo Nordisk (NVO), which fell 3.7% and 2.1% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Cellectis (CLLS), which lost 1.9% and 1.3% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which advanced 16.7% and 8.8% respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company Verona Pharma (VRNA), which increased 3.5% and 1.7% respectively.
The decliners from the UK and Ireland were led by educational publisher Pearson (PSO) and hospitality company InterContinental Hotels Group (IHG), which dropped 3.6% and 3.1% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and cruise line operator Carnival (CUK), which were down 5% and 2.9% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。